134 related articles for article (PubMed ID: 32495891)
21. A SOCS-1 promoter variant is associated with total serum IgE levels.
Mostecki J; Cassel SL; Klimecki WT; Stern DA; Knisz J; Iwashita S; Graves P; Miller RL; van Peer M; Halonen M; Martinez FD; Vercelli D; Rothman PB
J Immunol; 2011 Sep; 187(5):2794-802. PubMed ID: 21795592
[TBL] [Abstract][Full Text] [Related]
22. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
[TBL] [Abstract][Full Text] [Related]
23. Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer.
Ghafouri-Fard S; Oskooei VK; Azari I; Taheri M
World J Surg Oncol; 2018 Nov; 16(1):226. PubMed ID: 30453988
[TBL] [Abstract][Full Text] [Related]
24. The suppressor of cytokine signaling-1 (
Tukek T; Pehlivan S; Medetalibeyoglu A; Serin I; Oyacı Y; Arıcı H; Senkal N; Pehlivan M; Isoglu-Alkac U; Kose M
Pathog Glob Health; 2023 Jun; 117(4):392-400. PubMed ID: 36448222
[TBL] [Abstract][Full Text] [Related]
25. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
26. Association between TP53 polymorphisms and chronic lymphocytic leukemia.
Zhang WJ; Guo SL; Yin G; Wang GS; Wang ZR; Dong J; Li QR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12073-12079. PubMed ID: 33336725
[TBL] [Abstract][Full Text] [Related]
27. Correlation between AT1R gene polymorphism and epilepsy secondary to cerebral infarction.
Song LL; Wang YM; Wu XX; Zhu LX; Pan F; Chen YM
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6873-6880. PubMed ID: 32633380
[TBL] [Abstract][Full Text] [Related]
28. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
Zhang MY; Fung TK; Chen FY; Chim CS
J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
[TBL] [Abstract][Full Text] [Related]
29. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
30. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
[TBL] [Abstract][Full Text] [Related]
31. The expression of SOCS is altered in rheumatoid arthritis.
Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O
Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036
[TBL] [Abstract][Full Text] [Related]
32. DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.
Zhao XQ; Cao WJ; Yang HP; Yang XW; Tang P; Sun L; Gao X
Tumour Biol; 2016 Aug; 37(8):10393-402. PubMed ID: 26846104
[TBL] [Abstract][Full Text] [Related]
33. Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia.
Guillem V; Amat P; Cervantes F; Alvarez-Larrán A; Cervera J; Maffioli M; Bellosillo B; Collado M; Marugán I; Martínez-Ruiz F; Hernández-Boluda JC
Leuk Res; 2012 Feb; 36(2):174-81. PubMed ID: 21724255
[TBL] [Abstract][Full Text] [Related]
34. Characterization of variation in the canine suppressor of cytokine signaling-2 (SOCS2) gene.
Rincón G; Young AE; Bannasch DL; Medrano JF
Genet Mol Res; 2007 Mar; 6(1):144-51. PubMed ID: 17469064
[TBL] [Abstract][Full Text] [Related]
35. Correlations of IL-18 and IL-6 gene polymorphisms and expression levels with onset of glioma.
Yang Y; Song YJ; Nie QB; Wang YF; Zhang M; Mao GS
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1475-1483. PubMed ID: 35302191
[TBL] [Abstract][Full Text] [Related]
36. Absence of suppressor of cytokine signaling 2 turns cardiomyocytes unresponsive to LIF-dependent increases in Ca
Rocha-Resende C; Guedes de Jesus IC; Roman-Campos D; Miranda AS; Alves F; Resende RR; Dos Santos Cruz J; Machado FS; Guatimosim S
Am J Physiol Cell Physiol; 2017 Apr; 312(4):C478-C486. PubMed ID: 28122728
[TBL] [Abstract][Full Text] [Related]
37. Correlations of CYP11B2 gene polymorphisms with eclampsia.
Zou AX; Zhu FX; Jiang MX; Bao D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10338-10345. PubMed ID: 33155189
[TBL] [Abstract][Full Text] [Related]
38. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
39. Expression of SOCS1, SOCS2, and SOCS3 in growth hormone-stimulated skin fibroblasts from children with idiopathic short stature.
Ocaranza P; Morales F; Román R; Iñiguez G; Fernando C
J Pediatr Endocrinol Metab; 2012; 25(3-4):273-8. PubMed ID: 22768656
[TBL] [Abstract][Full Text] [Related]
40. Associations of IL-18 and IL-9 expressions and gene polymorphisms with asthma.
Chen LX; Xu CM; Gao F; Zhu MF; Xu MJ; Zhang JR; Qian WX
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6931-6938. PubMed ID: 32633386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
